Skip to main content
Top
Published in: Inflammation 3/2012

01-06-2012

Synergism Between Fentanyl and Tramadol in Tonic Inflammatory Pain: the Orofacial Formalin Test

Authors: Hugo F. Miranda, Viviana Noriega, Ramiro J. Zepeda, Fernando Sierralta, Juan C. Prieto

Published in: Inflammation | Issue 3/2012

Login to get access

Abstract

Opioids have been used for long time to management of pain, the coadministration of two opioids may induce synergism. The present study was conducted to determine the antinociceptive interaction between the dual mechanism of action of tramadol compared to the main of fentanyl antinociception in the orofacial formalin which represents a model of persistent cutaneous nociception in the region innervated by the trigeminal nerve. The i.p. administration of tramadol and fentanyl induced a dose-dependent antinociception with an ED50 of 2.97 ± 0.32 mg/kg for phase I and 1.79 ± 0.30 mg/kg for phase II and 0.062 ± 0.0040 mg/kg in phase I and 0.041 ± 0.0039 mg/kg in phase II, respectively. The coadministration of fentanyl with tramadol induced synergism in both phases of the test with an interaction index of 0.343 and 0.163 for phase I and phase II, respectively. This finding could be explained by the more complex pharmacology of tramadol compared to fentanyl.
Literature
1.
go back to reference Waldhoer, M., S.E. Bartlett, and J.L. Whistler. 2004. Opioid receptors. Annual Review of Biochemistry 73: 953–990.PubMedCrossRef Waldhoer, M., S.E. Bartlett, and J.L. Whistler. 2004. Opioid receptors. Annual Review of Biochemistry 73: 953–990.PubMedCrossRef
2.
go back to reference Trescot, A.M., S. Datta, M. Lee, and H. Hansen. 2008. Opioid pharmacology. Pain Physician 11: S133–S153.PubMed Trescot, A.M., S. Datta, M. Lee, and H. Hansen. 2008. Opioid pharmacology. Pain Physician 11: S133–S153.PubMed
3.
go back to reference Raffa, R.B., and D.J. Stone. 2008. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice. The Journal of Pharmacology and Experimental Therapeutics 303: 557–562. Raffa, R.B., and D.J. Stone. 2008. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice. The Journal of Pharmacology and Experimental Therapeutics 303: 557–562.
4.
go back to reference Kelly, S., K.S. Lewis, and N.H. Han. 1997. Tramadol: a new centrally acting analgesic. American Journal of Health-System Pharmacy 54: 643–652. Kelly, S., K.S. Lewis, and N.H. Han. 1997. Tramadol: a new centrally acting analgesic. American Journal of Health-System Pharmacy 54: 643–652.
5.
go back to reference Curatolo, M., and G. Sveticic. 2002. Drug combination in pain treatment: a review of the published evidence and a method for finding the optimal combination. Best Practice & Research Clinical Anaesthesiology 216: 507–512.CrossRef Curatolo, M., and G. Sveticic. 2002. Drug combination in pain treatment: a review of the published evidence and a method for finding the optimal combination. Best Practice & Research Clinical Anaesthesiology 216: 507–512.CrossRef
6.
go back to reference Smith, H.S. 2008. Combination opioids analgesics. Pain Physician 11: 202–214. Smith, H.S. 2008. Combination opioids analgesics. Pain Physician 11: 202–214.
7.
go back to reference Stein, C., J.D. Clark, U. Oh, M.R. Vasko, G.L. Wilcox, A.C. Overland, T.W. Vanderah, and R.H. Spencer. 2009. Peripheral mechanisms of pain and analgesia. Brain Research Reviews 60: 90–113.PubMedCrossRef Stein, C., J.D. Clark, U. Oh, M.R. Vasko, G.L. Wilcox, A.C. Overland, T.W. Vanderah, and R.H. Spencer. 2009. Peripheral mechanisms of pain and analgesia. Brain Research Reviews 60: 90–113.PubMedCrossRef
8.
go back to reference Luccarini, P., A. Childeric, A.M. Gayder, D. Voisin, and R. Dallel. 2006. The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. The Journal of Pain 7: 908–914.PubMedCrossRef Luccarini, P., A. Childeric, A.M. Gayder, D. Voisin, and R. Dallel. 2006. The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. The Journal of Pain 7: 908–914.PubMedCrossRef
9.
go back to reference Miranda, H.F., F. Sierralta, and J.C. Prieto. 2009. Synergism between NSAIDs in the orofacial formalin test in mice. Pharmacology, Biochemistry, and Behavior 92: 314–318.PubMedCrossRef Miranda, H.F., F. Sierralta, and J.C. Prieto. 2009. Synergism between NSAIDs in the orofacial formalin test in mice. Pharmacology, Biochemistry, and Behavior 92: 314–318.PubMedCrossRef
10.
go back to reference Tallarida, R.J. 2000. Drug synergism and dose-effect data analysis. Boca Ratón: Chapman & Hall/CRC Press. p. 26-131. Tallarida, R.J. 2000. Drug synergism and dose-effect data analysis. Boca Ratón: Chapman & Hall/CRC Press. p. 26-131.
11.
go back to reference Dubuisson, D., and S.G. Dennis. 1977. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161–174.PubMedCrossRef Dubuisson, D., and S.G. Dennis. 1977. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161–174.PubMedCrossRef
12.
go back to reference Tjølsen, A., O.-G. Berge, S. Hunskaar, J.H. Rosland, and K. Hole. 1992. The formalin test: an evaluation of the method. Pain 51: 5–17.PubMedCrossRef Tjølsen, A., O.-G. Berge, S. Hunskaar, J.H. Rosland, and K. Hole. 1992. The formalin test: an evaluation of the method. Pain 51: 5–17.PubMedCrossRef
13.
go back to reference Sessle, B.J. 2005. Peripheral and central mechanisms of orofacial pain and their clinical correlates. Minerva Anesthesiology 71: 117–136. Sessle, B.J. 2005. Peripheral and central mechanisms of orofacial pain and their clinical correlates. Minerva Anesthesiology 71: 117–136.
14.
go back to reference Bolan, E.A., R.J. Tallarida, and G.W. Pasternak. 2002. Synergy between mu opioid ligands, evidence for functional interactions among mu opioid receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics 303: 557–562.PubMedCrossRef Bolan, E.A., R.J. Tallarida, and G.W. Pasternak. 2002. Synergy between mu opioid ligands, evidence for functional interactions among mu opioid receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics 303: 557–562.PubMedCrossRef
15.
go back to reference Pan, Y.X., J. Xu, H.S. Moskowitz, M. Xu, and G.W. Pasternak. 2005. Identification of four novel exon 5 splice variants of the mouse μ- opioid receptor gene: Functional consequences of C-terminal splicing. Molecular Pharmacology 68: 866–875.PubMed Pan, Y.X., J. Xu, H.S. Moskowitz, M. Xu, and G.W. Pasternak. 2005. Identification of four novel exon 5 splice variants of the mouse μ- opioid receptor gene: Functional consequences of C-terminal splicing. Molecular Pharmacology 68: 866–875.PubMed
16.
go back to reference Munro, G., C.A. Baek, H.K. Erichsen, A.N. Nielsen, E.Ø. Nielsen, J. Scheel-Kruger, P. Weikop, and D. Peters. 2008. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3- yl]-propan-1- one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol. Neuropharmacology 54: 331–343.PubMedCrossRef Munro, G., C.A. Baek, H.K. Erichsen, A.N. Nielsen, E.Ø. Nielsen, J. Scheel-Kruger, P. Weikop, and D. Peters. 2008. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3- yl]-propan-1- one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol. Neuropharmacology 54: 331–343.PubMedCrossRef
17.
go back to reference Ozdogan, U.K., and M.S. Lahdesmaki. 2006. The analgesic efficacy of partial opioid agonists is increased in mice with targeted inactivation of the α2A-adrenoceptor gene. European Journal of Pharmacology 529: 105–113.PubMedCrossRef Ozdogan, U.K., and M.S. Lahdesmaki. 2006. The analgesic efficacy of partial opioid agonists is increased in mice with targeted inactivation of the α2A-adrenoceptor gene. European Journal of Pharmacology 529: 105–113.PubMedCrossRef
18.
go back to reference Gercek, A., Z. Eti, F.Y. Gogus, and A. Sav. 2004. The analgesic and antiinflammatory effects of subcutaneous bupivacaine, morphine and tramadol in rats. Agriculture 16: 53–58. Gercek, A., Z. Eti, F.Y. Gogus, and A. Sav. 2004. The analgesic and antiinflammatory effects of subcutaneous bupivacaine, morphine and tramadol in rats. Agriculture 16: 53–58.
19.
go back to reference Miranda, H.F., M.M. Puig, M.A. Romero, and J.C. Prieto. 2009. Effects of tramadol and dexketoprofen on analgesia and gastrointestinal transit in mice. Fundamental and Clinical Pharmacology 23: 81–88.PubMedCrossRef Miranda, H.F., M.M. Puig, M.A. Romero, and J.C. Prieto. 2009. Effects of tramadol and dexketoprofen on analgesia and gastrointestinal transit in mice. Fundamental and Clinical Pharmacology 23: 81–88.PubMedCrossRef
20.
go back to reference Romero, A., H.F. Miranda, and M.M. Puig. 2010. Antinociceptive effects of morphine, fentanyl, tramadol and their combination in morphine-tolerant mice. Pharmacology, Biochemistry, and Behavior 97: 363–369.PubMedCrossRef Romero, A., H.F. Miranda, and M.M. Puig. 2010. Antinociceptive effects of morphine, fentanyl, tramadol and their combination in morphine-tolerant mice. Pharmacology, Biochemistry, and Behavior 97: 363–369.PubMedCrossRef
21.
go back to reference Romero, A., H.F. Miranda, and M.M. Puig. 2010. Analysis of the opioide–opioid combinations according to the nociceptive stimulus in mice. Pharmacological Research 61: 511–518.PubMedCrossRef Romero, A., H.F. Miranda, and M.M. Puig. 2010. Analysis of the opioide–opioid combinations according to the nociceptive stimulus in mice. Pharmacological Research 61: 511–518.PubMedCrossRef
22.
go back to reference Sirohi, S., S.V. Dighe, E.A. Walker, and B.C. Yoburn. 2008. The analgesic efficacy of fentanyl: Relationship to tolerance and μ-opioid receptor regulation. Pharmacology, Biochemistry, and Behavior 91: 115–120.PubMedCrossRef Sirohi, S., S.V. Dighe, E.A. Walker, and B.C. Yoburn. 2008. The analgesic efficacy of fentanyl: Relationship to tolerance and μ-opioid receptor regulation. Pharmacology, Biochemistry, and Behavior 91: 115–120.PubMedCrossRef
23.
go back to reference Barrera, N.P., B. Morales, S. Torres, and M. Villalon. 2005. Principles: Mechanisms and modelling of synergism in cellular responses. Trends in Pharmacological Sciences 26: 526–532.PubMedCrossRef Barrera, N.P., B. Morales, S. Torres, and M. Villalon. 2005. Principles: Mechanisms and modelling of synergism in cellular responses. Trends in Pharmacological Sciences 26: 526–532.PubMedCrossRef
24.
go back to reference Kenakin, T. 2007. Collateral efficacy in drug discovery: Taking advantage of the good (allosteric) nature of 7TM receptors. Trends in Pharmacological Sciences 28: 407–415.PubMedCrossRef Kenakin, T. 2007. Collateral efficacy in drug discovery: Taking advantage of the good (allosteric) nature of 7TM receptors. Trends in Pharmacological Sciences 28: 407–415.PubMedCrossRef
Metadata
Title
Synergism Between Fentanyl and Tramadol in Tonic Inflammatory Pain: the Orofacial Formalin Test
Authors
Hugo F. Miranda
Viviana Noriega
Ramiro J. Zepeda
Fernando Sierralta
Juan C. Prieto
Publication date
01-06-2012
Publisher
Springer US
Published in
Inflammation / Issue 3/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9420-7

Other articles of this Issue 3/2012

Inflammation 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.